secwatch.observer — SEC 8-K summary
======================================

Issuer:     Syra Health Corp (SYRA)
CIK:        0001922335
Form:       8-K
Filed at:   2025-03-11T23:59:59+00:00
Accession:  0001493152-25-009882
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Syra Health FY 2024 revenue $8.0M (+45% YoY); Q4 net loss nearly halved to $504K; PopHealth up 132%
--------------------------------------------------------------------------------

- FY 2024 revenue $8.0M (+45% YoY); net loss $3.8M vs $2.9M in 2023.
- Q4 2024 revenue $2.0M (+14% YoY); net loss $504K vs $995K (halved YoY).
- Population Health revenue $1.7M in 2024 (+132% YoY); Q4 PopHealth up 285% YoY.
- Cash $2.4M, no long-term debt; 2025 guidance low double-digit % revenue growth.
- Secured contract extensions: Indiana $1.5M, Tennessee $450K (up to $1.3M), DC $1M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1922335/000149315225009882/0001493152-25-009882-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1922335/000149315225009882/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009882

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer